Skip to main content

New England Biolabs Supplies DNA Sample Prep Reagents to Sanger Institute


New England Biolabs said last week that it will supply next-generation sequencing library construction reagents to the Wellcome Trust Sanger Institute.

New England Biolabs, based in Ipswich, Mass., will supply the Sanger Institute with NEBNext DNA Sample Prep Reagent Sets, which contain enzymes and buffers that are suited for preparing next-generation sequencing samples and expression libraries.

Reagents are available for each step of library construction workflow and are compatible with the Illumina GAII, Roche/454 GS FLX Titanium, and Life Technologies SOLiD 3 platforms.

"We are extremely pleased that the Wellcome Trust Sanger Institute, as a world-leading genome center, has determined that our reagents meet their high standards," Peter Nathan, director of global business development at New England Biolabs, said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.